GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (OTCPK:SNPHY) » Definitions » Days Sales Outstanding

Santen Pharmaceutical Co (Santen Pharmaceutical Co) Days Sales Outstanding : 103.16 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Santen Pharmaceutical Co Days Sales Outstanding?

Santen Pharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2024 was $597 Mil. Santen Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was $528 Mil. Hence, Santen Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 103.16.

The historical rank and industry rank for Santen Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SNPHY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 116.02   Med: 128.49   Max: 135.23
Current: 116.02

During the past 13 years, Santen Pharmaceutical Co's highest Days Sales Outstanding was 135.23. The lowest was 116.02. And the median was 128.49.

SNPHY's Days Sales Outstanding is ranked worse than
81.5% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 72.34 vs SNPHY: 116.02

Santen Pharmaceutical Co's Days Sales Outstanding declined from Mar. 2023 (115.42) to Mar. 2024 (103.16).


Santen Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Santen Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co Days Sales Outstanding Chart

Santen Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 127.66 134.40 140.04 143.51 127.31

Santen Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 115.42 136.84 125.55 104.24 103.16

Competitive Comparison of Santen Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santen Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Days Sales Outstanding falls into.



Santen Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Santen Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

Days Sales Outstanding (A: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (801.747 + 604.324) / 2 ) / 2015.537*365
=703.0355 / 2015.537*365
=127.31

Santen Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (589.902 + 604.324) / 2 ) / 528.185*365 / 4
=597.113 / 528.185*365 / 4
=103.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Santen Pharmaceutical Co  (OTCPK:SNPHY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Santen Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Santen Pharmaceutical Co (Santen Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Santen Pharmaceutical Co (Santen Pharmaceutical Co) Headlines

From GuruFocus

Matthews Japan Fund Comments on Santen Pharmaceutical

By Sydnee Gatewood Sydnee Gatewood 04-23-2020

Matthews Japan Fund 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood 04-23-2020